There’s excitement: about drug policy progress; about opportunity access for more people in need to have; about the prospect of with the ability to give patients more appropriate and tailor-made procedure with no constraints imposed by medical trials and rigid protocols. And afterwards you will discover fears: that proof remains inadequate, and g